Peter Goldschmidt
Chief Executive Officer at STADA ARZNEIMITTEL
Profile
Presently, Peter Goldschmidt occupies the position of Chairman-Executive Board at STADA Arzneimittel AG, Chief Executive Officer of Fougera Pharmaceuticals, Inc. and President of Sandoz, Inc. He is also on the board of Association for Accessible Medicines. He previously held the position of Head-Marketing at Novartis Pharma (Sweeden), Country President at Novartis Healthcare Philippines, Inc., Head-Central & Eastern Europe at Sandoz International GmbH and Head-Sales & Marketing at Novartis Pharmaceuticals. Peter Goldschmidt received a graduate degree and an undergraduate degree from the University of Münster.
Peter Goldschmidt active positions
Companies | Position | Start |
---|---|---|
STADA ARZNEIMITTEL | Chief Executive Officer | 01/09/2018 |
SCHOTT PHARMA AG & CO. KGAA | Chairman | - |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | President | 01/07/2013 |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Director/Board Member | - |
Nidda German Topco GmbH
Nidda German Topco GmbH MiscellaneousMiscellaneous Part of Nidda Topco SARL, Nidda German Topco GmbH is an investment holding company. The company is based in Bad Vilbel, Germany. The CEOs of the private company are Andreas Grundhöfer and Peter Goldschmidt. | Chief Executive Officer | - |
Former positions of Peter Goldschmidt
Companies | Position | End |
---|---|---|
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | 01/01/2013 |
Novartis Healthcare Philippines, Inc. | Corporate Officer/Principal | 01/01/2008 |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Sales & Marketing | 01/01/2007 |
Novartis Pharma (Sweeden) | Sales & Marketing | 01/01/2001 |
░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Peter Goldschmidt
University of Münster | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SCHOTT PHARMA AG & CO. KGAA | Health Technology |
Private companies | 10 |
---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
GfK SE
GfK SE Miscellaneous Commercial ServicesCommercial Services GfK SE engages in the provision of market research services. Its solutions include consumer insights, consumer panels, distribution and supply chain management, geomarketing, in-store intelligence, media measurement, online pricing intelligence, point of sales analytics, point of sales tracking, printed advertising tracking, product catalogs, shopper, and trends and forecasting. The company was founded in 1984 and is headquartered in Nuremberg, Germany. | Commercial Services |
STADA Arzneimittel AG
STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Health Technology |
Novartis Healthcare Philippines, Inc. | |
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Health Technology |
Novartis Pharma (Sweeden) | |
Nidda German Topco GmbH
Nidda German Topco GmbH MiscellaneousMiscellaneous Part of Nidda Topco SARL, Nidda German Topco GmbH is an investment holding company. The company is based in Bad Vilbel, Germany. The CEOs of the private company are Andreas Grundhöfer and Peter Goldschmidt. | Miscellaneous |
- Stock Market
- Insiders
- Peter Goldschmidt